Tyche Industries Limited manufactures and sells active pharmaceutical ingredients and intermediates in India and internationally. The company also provides chiral intermediates and nutraceuticals; and contract drug substance and analytical development, as well as contract development, manufacturing, and analytical development services. It primarily exports its products to the United States and Europe. Tyche Industries Limited was incorporated in 1998 and is based in Hyderabad, India.
Rs. Crores · hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales 9.10
16.20
10.58
14.16
12.70
12.37
17.75
20.54
15.52
14.20
22.22
16.04
17.05
Expenses 10.79
16.87
9.49
14.29
10.76
12.55
12.92
15.82
12.90
12.32
17.39
12.91
14.25
Operating Profit -1.69
-0.67
1.09
-0.13
1.94
-0.18
4.83
4.72
2.62
1.88
4.83
3.13
2.80
OPM % -18.57
-4.14
10.30
-0.92
15.28
-1.46
27.21
22.98
16.88
13.24
21.74
19.51
16.42
Other Income 2.26
2.96
1.85
2.65
1.77
2.01
2.04
1.14
1.52
1.59
1.51
1.53
1.29
Depreciation 0.62
0.59
0.48
0.47
0.45
0.50
0.50
0.49
0.49
0.54
0.48
0.47
0.46
Interest 0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit before tax -0.05
1.70
2.46
2.05
3.26
1.33
6.37
5.37
3.65
2.93
5.86
4.19
3.63
Tax % -20.00
31.76
26.02
25.85
25.46
28.57
25.75
25.51
24.93
28.67
26.79
25.30
25.07
Net Profit -0.04
1.15
1.82
1.52
2.43
0.94
4.74
3.99
2.73
2.10
4.29
3.14
2.71
EPS in Rs -0.04
1.12
1.78
1.48
2.37
0.92
4.62
3.89
2.66
2.05
4.19
3.06
2.64
Annual · Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
53.63 65.47 69.51 75.39 62.27 78.24 73.70 53.95 51.60 42.61 54.08 63.86
Expenses
51.39 54.19 56.86 59.24 51.30 53.52 52.31 44.78 42.57 36.62 51.16 56.80
Operating Profit
2.24 11.28 12.65 16.15 10.97 24.72 21.39 9.17 9.03 5.99 2.92 7.06
OPM %
4.18 17.23 18.20 21.42 17.62 31.60 29.02 17.00 17.50 14.06 5.40 11.06
Other Income
9.22 7.42 5.92 4.71 3.46 3.75 3.68 2.52 1.69 1.89 1.68 0.25
Interest
0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.08 0.29 1.11
Depreciation
2.00 1.99 1.94 1.77 1.79 1.72 1.74 1.84 1.85 1.87 1.76 3.34
Profit before tax
9.46 16.71 16.63 19.09 12.64 26.74 23.33 9.85 8.86 5.93 2.55 2.86
Tax %
26.74 25.73 26.40 25.72 26.11 25.24 24.73 27.41 33.86 48.06 3.53 32.87
Net Profit
6.94 12.41 12.24 14.17 9.33 19.98 17.56 7.15 5.86 3.08 2.47 1.93
EPS in Rs
6.77 12.11 11.94 13.82 9.10 19.49 17.13 6.98 5.72 3.00 2.41 1.88
Dividend Payout %
51.69 24.78 20.94 0.00 16.48 5.13 0.00 7.17 8.75 16.61 20.71 26.50
Annual · Rs. Crores — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
10.25 10.25 10.25 10.25 10.25 10.25 10.25 10.25 10.25 10.23 10.23 10.23
Reserves
130.23 126.46 116.49 106.51 93.97 85.72 66.93 50.02 42.88 37.66 35.36 33.56
Borrowings
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.07 0.00 10.83 8.68
Other Liabilities
7.56 10.69 7.95 19.95 16.05 20.98 17.52 13.70 13.52 13.10 11.01 11.51
Total Liabilities
148.04 147.40 134.69 136.71 120.27 116.95 94.70 74.01 66.72 60.99 67.43 63.98
Fixed Assets
18.88 16.48 17.90 16.61 16.63 17.93 17.67 19.15 19.84 26.57 28.40 28.98
CWIP
0.00 0.16 0.00 0.00 0.00 0.53 0.00 0.00 0.00 0.33 0.33 0.38
Investments
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
129.16 130.76 116.79 120.10 103.64 98.49 77.03 54.86 46.88 34.09 38.70 34.62
Total Assets
148.04 147.40 134.69 136.71 120.27 116.95 94.70 74.01 66.72 60.99 67.43 63.98
Annual · Rs. Crores — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
2.85 8.54 7.71 6.43 4.46 15.45 15.21 3.75 5.04 11.37 11.96 2.31
Cash from Investing Activity
-8.95 -0.62 3.94 -3.12 3.16 0.42 2.04 0.63 6.29 0.60 -1.34 -0.98
Cash from Financing Activity
-3.07 -2.56 -2.05 -1.54 -1.02 -1.02 -0.62 -0.07 -0.60 -10.59 1.59 -3.24
Net Cash Flow
-9.17 5.37 9.61 1.77 6.59 14.85 16.63 4.31 10.72 1.38 12.20 -1.90
Free Cash Flow
-1.41 7.84 4.48 4.68 4.58 12.95 14.95 2.61 10.25 11.33 10.82 1.33
CFO/OP %
127.00 76.00 61.00 40.00 41.00 62.00 71.00 41.00 56.00 190.00 410.00 33.00
Annual · Days / % — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
132.99 95.45 100.40 106.90 96.25 79.91 64.04 68.81 68.05 81.12 106.71 90.65
Inventory Days
149.93 244.61 157.11 195.21 148.32 148.08 121.71 122.85 85.37 83.68 67.76 138.26
Days Payable
37.78 85.26 47.91 134.49 77.86 93.04 91.41 95.79 86.81 130.50 92.82 75.69
Cash Conversion Cycle
245.13 254.79 209.60 167.62 166.71 134.95 94.34 95.87 66.61 34.30 81.65 153.22
Working Capital Days
177.43 150.86 144.30 128.74 121.22 82.76 77.11 86.53 66.63 60.48 21.46 77.39
ROCE %
6.83 12.67 13.66 17.39 13.32 32.04 33.92 17.36 17.55 11.52 5.22 7.37
% holding — latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
61.97
61.97
61.97
62.06
61.97
61.97
61.97
61.97
61.97
61.97
61.97
61.97
Public
38.03
38.03
38.03
37.95
38.03
38.03
38.03
38.03
38.03
38.03
38.04
38.04
No. of Shareholders
6,786
6,952
7,152
7,257
7,376
7,425
7,308
7,264
7,477
7,867
8,221
8,461
21 records